/Moderna%20Inc%20meds-by%20Ascannio%20via%20Shutterstock.jpg)
Moderna, Inc. (MRNA), based in Cambridge, Massachusetts, is a leading biotechnology company specializing in mRNA therapeutics and vaccines. With a market cap of $30.4 billion, Moderna has transformed the pharmaceutical industry through its groundbreaking mRNA technology, developing treatments for various diseases.
Companies valued at $10 billion or more are generally considered "large-caps," and Moderna fits this criterion perfectly, signifying its substantial size, stability, and influence in the biotechnology industry.